ALKALI · Basic Materials · Specialty Chemicals
| Share price | ₹78.66 |
| Market cap | ₹80 Cr |
| P/E ratio | 74.9 |
| P/B ratio | 1.8 |
| ROE | 5.0% |
| ROCE | 10.5% |
| Dividend yield | 1.53% |
| Book value | ₹43.85 |
| Year | Sales | Net profit | OPM |
|---|---|---|---|
| 2026 | ₹93 Cr | ₹1 Cr | 5.7% |
| 2025 | ₹82 Cr | ₹-6 Cr | -5.4% |
| 2024 | ₹82 Cr | ₹1 Cr | 5.3% |
| 2023 | ₹86 Cr | ₹3 Cr | 6.5% |
| 2022 | — | — | — |
Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, carbazole, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, quinoline, tetrazole, an